News

10 Professionals Predict the Future of Clinical Trials

Vice President of Sales, Joe Ehrline, speaks with Xtalks about the future of clinical trials at the Drug Information Association (DIA) Global Annual Meeting 2019 in San Diego, CA. “My personal take on the future of clinical trials is on harnessing the data that is out there in clinical trials. Right now, so many companies are struggling with…

Read More

Saama Collaborates with Researchers to Assess Technology Adoption in Drug Development

Collaboration Continues Saama’s Commitment to Academic Alliances that Advance Clinical Operations CAMPBELL, CA – (July 9, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics company, today announced a collaboration with researchers at the Tufts Center for the Study of Drug Development (Tufts CSDD) at Tufts University School of Medicine to ascertain how…

Read More

Leveraging Patient-Centric Data Analytics to Accelerate Clinical Trials

Director of Marketing Programs, Crystal Black, detailed the significant applications of AI-fueled data analytics in the life sciences industry in this fascinating article on PharmaVoice.  “A qualified data analytics partner brings a variety of benefits to the table that enable sponsors to overcome these and other obstacles to leverage AI solutions that accelerate clinical trials.…

Read More

AI IRL Podcast: Can AI Save Billions in Clinical Research Costs?

When the cost of drug development has increased a few hundred fold, how do you find a way to cut expenses and time? AI to the rescue. AI is poised to make a major change in the economics of medical research, according to Crystal Black, Director of Marketing Programs for Saama Technologies. “We’re geared toward the mission…

Read More

Saama Challenges Analytics Industry to Guarantee Data Platforms to Help Accelerate Drug Development

Company Leads Call-to-Action by Issuing Saama Product Guarantee on Clinical Trials Day CAMPBELL, CA – (May 20, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics company, issued a call-to-action on Clinical Trials Day urging the analytics industry to commit to timely deployment of solutions for biopharmaceutical companies and the elimination of launch…

Read More

Board of Advisors Member, Opinder Bawa, Writes Article for PharmExec.com

VP for Information Technology and Chief Information Officer at University of San Francisco and Saama Clinical Board of Advisors Member, Opinder Bawa, published an article on PharmExec.com examining the role of AI in life science industry transformation through a historical lens. “Today we see how AI substantially increases or effectively disrupts clinical trial supply chain…

Read More

Saama’s Latest Funding Covered by Endpoints News

Saama’s recent $40M funding from Perceptive Advisors was covered by Endpoints News in an article reviewing Saama’s role in the adoption of artificial intelligence to speed up drug discovery and development. This article asserts that, “Optimization and efficiency are goals that everyone working in R&D can rally around, and AI promises to be a tool that…

Read More

Related Posts